Establishing a cardiovascular health and wellness program in a community pharmacy: Screening for metabolic syndrome
Julie L. Olenak, PharmD; Meghan Calpin, PharmD
J Am Pharm Assoc (2003) 2010;50:32-36. doi:10.1331/JAPhA.2010.08104


Objectives  To implement a comprehensive service to screen for metabolic syndrome, assess the prevalence of metabolic syndrome, determine the 10-year risk of developing coronary heart disease (CHD), and measure the effectiveness of patient education on lifestyle modifications.

Design  Cross-sectional study.

Setting  Community pharmacy in Pennsylvania between February 2006 and August 2007.

Patients  239 patients 18 years of age or older with no history of CHD.

Intervention  Participating patients were screened for metabolic syndrome, Framingham risk assessment, and medication use. Test results were discussed and patients were educated on metabolic syndrome and lifestyle recommendations. A follow-up survey was administered.

Main outcome measures  Prevalence of metabolic syndrome in the study population, Framingham risk assessment of those with metabolic syndrome, proportion of patients with self-reported lifestyle modifications.

Results  The prevalence of metabolic syndrome in our study population was 36%. The Framingham risk assessment of patients with metabolic syndrome and no known history of diabetes revealed that 65.3% were at low risk, 26.4% were at moderate risk, and 8.3% were at high risk for CHD. Of the study population with no known history of prediabetes or diabetes, 26% had an abnormal glucose reading. Of those with metabolic syndrome, 87% self-reported a lifestyle modification in the area of diet, exercise, or weight loss in the following 3- to 6-month follow-up period.

Conclusion  Pharmacists have an important role in screening patients for risk factors associated with metabolic syndrome. By providing education on lifestyle modifications, pharmacists can increase the likelihood that patients with metabolic syndrome implement lifestyle changes. A metabolic syndrome screening and education program can be successfully implemented in a community pharmacy setting.

Sign In
APhA Members 
Welcome to JAPhA.org! Please log in below using your APhA username and password. Update your APhA profile.
Not a Subscriber
New to JAPhA? Become an APhA member to receive a full subscription to both the print and online editions.


Register for a FREE limited account to benefit from personalization features such as alerts.


 American Heart Association. Metabolic syndrome. Accessed at www.americanheart.org/presenter.jhtml?identifier=4756, July 16,  2008.
Ford E, Giles W, Mokdad A. Increasing prevalence of the metabolic syndrome among US adults.  Diabetes Care. 2004;27:2444–9.[PubMed][CrossRef]
Grundy S, Cleeman J, Daniels S, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement.  Circulation. 2005;112;2735–52.[PubMed]
Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics 2008 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee.  Circulation. 2008;117:e25–146.[PubMed]
Malik S, Wong N, Franklin S, et al. Impact of metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.  Circulation. 2004;110:1245–50.[PubMed]
Ciaardulli L, Goode J. Using health observances to promote wellness in community pharmacies.  J Am Pharm Assoc. 2003;43:13–6.
 National Heart Lung and Blood Institute. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). Accessed at www.nhlbi.nih.gov/guidelines/hypertension, May 20,  2009.
 National Cholesterol Education Program. Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Accessed at www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf, August 7, 2008.
McNeill A, Rosamond W, Girman C, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities study.  Diabetes Care. 2005;28:385–90.[PubMed]
Rodis J, Thomas RA. Stepwise approach to developing point-of-care testing services in the community/ambulatory pharmacy setting.  J Am Pharm Assoc. 2006;46:594–604.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Please read the other comments before you post yours. Comments are moderated and will appear on the site at the discertion of the editorial staff.
* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe

Related Content

Customize your page view by dragging & repositioning the boxes below.

JAPhA Articles
Topic Collections
  • Print
  • PDF Download
  • Email
  • Share
  • Get Citation
  • Submit Comment
  • Article Alerts
    Please Wait... Processing your request... Please Wait.
    You must sign in to sign-up for alerts.

    Please confirm that your email address is correct, so you can successfully receive this alert.

  • Letters To Editor
  • Reprints